Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Express Scripts
Cantor Fitzgerald
US Army
Moodys
Julphar

Generated: September 17, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MIGALASTAT HYDROCHLORIDE

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Clinical Trials for Migalastat Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00214500 A Study of AT1001 in Patients With Fabry Disease Completed Amicus Therapeutics Phase 2 The purpose of this study is to determine whether AT1001 (migalastat hydrochloride) is safe and effective in patients with Fabry disease.
NCT00283933 A 24-Week Safety and Pharmacodynamic Study of AT1001 in Patients With Fabry Disease Completed Amicus Therapeutics Phase 2 The purpose of this study is to collect information on the safety of AT1001 (migalastat hydrochloride) and how AT1001 works in patients with Fabry disease.
NCT00283959 A 12-Week Safety and Pharmacodynamic Study of AT1001 in Patients With Fabry Disease Completed Amicus Therapeutics Phase 2 The purpose of this study is to collect information on the safety of AT1001 (migalastat hydrochloride) and how AT1001 works in patients with Fabry disease.
>Trial ID >Title >Status >Phase >Summary

Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Migalastat Hydrochloride

Condition Name

Condition Name for Migalastat Hydrochloride
Intervention Trials
Fabry Disease 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Migalastat Hydrochloride
Intervention Trials
Fabry Disease 16
Renal Insufficiency 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Migalastat Hydrochloride

Trials by Country

Trials by Country for Migalastat Hydrochloride
Location Trials
United States 56
Australia 9
United Kingdom 7
France 6
Canada 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Migalastat Hydrochloride
Location Trials
Georgia 8
New York 6
Texas 6
Pennsylvania 5
Virginia 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Migalastat Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Migalastat Hydrochloride
Clinical Trial Phase Trials
Phase 3 7
Phase 2 4
Phase 1 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Migalastat Hydrochloride
Clinical Trial Phase Trials
Completed 11
Not yet recruiting 3
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Migalastat Hydrochloride

Sponsor Name

Sponsor Name for Migalastat Hydrochloride
Sponsor Trials
Amicus Therapeutics 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Migalastat Hydrochloride
Sponsor Trials
Industry 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Harvard Business School
Baxter
Merck
Cantor Fitzgerald
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.